Evidence map›Paper›PMID 40982021›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

[

Caroline Boursier, Timothée Zaragori, Nicolas Garabedian, Marie Blonski, Tiphaine Obara, Luc Taillandier, Laetitia Imbert, Antoine Verger

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06614205 (Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06614205 completednot on this map

Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma

TypeobservationalSponsorCentral Hospital, Nancy, FranceRan2024 to 2025Enrolled11ConditionsMeningioma of BrainArmstumoral dosimetry by scintigraphy
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Caroline BoursierDepartment of Nuclear Medicine, CHRU Nancy, and Nancyclotep Imaging Platform, Nancy, F-54000, France. c.boursier@chru-nancy.fr.ORCID 0009-0005-2862-010X
Timothée ZaragoriUniversité de Lorraine, IADI, INSERM U1254, Nancy, F-54000, France.
Nicolas GarabedianDepartment of Nuclear Medicine, CHRU Nancy, and Nancyclotep Imaging Platform, Nancy, F-54000, France.
Marie BlonskiDepartment of Neuro-Oncology, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France.
Tiphaine ObaraDepartment of Neuro-Oncology, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France.
Luc TaillandierDepartment of Neuro-Oncology, Université de Lorraine, CHRU Nancy, Nancy, F-54000, France.
Laetitia ImbertDepartment of Nuclear Medicine, CHRU Nancy, and Nancyclotep Imaging Platform, Nancy, F-54000, France.
Antoine VergerDepartment of Nuclear Medicine, CHRU Nancy, and Nancyclotep Imaging Platform, Nancy, F-54000, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to reveal the factors affecting the therapeutic response of refractory meningiomas treated with [

methodsPatients with refractory and progressive meningiomas treated with [

resultsSixteen patients (60 [55;68] years old) underwent 4 [2;4] cycles of [

conclusion[

Indexed as

Meningeal NeoplasmsMeningiomaOctreotideOrganometallic CompoundsAgedFemaleHumansMaleMiddle AgedRadiometryRetrospective StudiesTreatment Outcomelutetium Lu 177 dotatateOctreotideOrganometallic Compounds[177Lu]Lu-DOTATATECZT cameraDosimetryMeningiomaRadionuclide therapy

Identifiers

PMID40982021

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.